What are the recommended management guidelines for diabetic ketoacidosis in infants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DKA Management in Infants

For infants with diabetic ketoacidosis, use continuous intravenous insulin infusion WITHOUT an initial bolus, combined with careful fluid resuscitation over 48 hours using isotonic saline, with meticulous attention to preventing cerebral injury through gradual correction of metabolic derangements.

Initial Assessment and Monitoring

Obtain immediately:

  • Venous blood gas (arterial not necessary for ongoing monitoring)
  • Blood glucose, electrolytes (especially potassium), BUN, creatinine
  • Calculate effective serum osmolality: 2[Na (mEq/L)] + glucose (mg/dL)/18
  • Urinalysis for ketones
  • Blood β-hydroxybutyrate (preferred over nitroprusside method for ketone monitoring) 1, 2

Monitor every 2-4 hours during treatment for glucose, electrolytes, venous pH, and anion gap 1.

Fluid Management

Initial resuscitation:

  • Administer 10 mL/kg isotonic (0.9%) saline bolus over 20-30 minutes
  • Avoid larger 20 mL/kg boluses in infants - recent evidence shows smaller volumes (10 mL/kg) may reduce adverse events compared to 20 mL/kg 3, 4

Ongoing rehydration:

  • Rehydrate over 48 hours (not 24-36 hours as in older protocols) 5
  • Use 0.9% saline initially for rehydration 4, 6
  • Calculate fluid as 1.5 times 24-hour maintenance requirements (approximately 5 mL/kg/h), not exceeding 2 times maintenance 1
  • Critical caveat: If osmolality >360 mmol/L, extend rehydration beyond 48 hours 6

Fluid composition:

  • Switch to 0.45% saline after initial stabilization to reduce risk of hyperchloremic acidosis and hypoglycemia associated with prolonged 0.9% saline use 3
  • Add 5% dextrose when blood glucose falls below 12-14 mmol/L (216-252 mg/dL) 6, 7

Insulin Therapy

Critical for infants: NO initial insulin bolus 1, 5

  • Start continuous IV regular insulin infusion at 0.1 units/kg/hour only after confirming potassium >3.3 mEq/L 1
  • Target glucose decline of 50-75 mg/dL per hour 1
  • If glucose doesn't fall by 50 mg/dL in first hour, verify hydration status, then double insulin infusion hourly until achieving target decline 1
  • When glucose reaches 12-14 mmol/L (216-252 mg/dL), reduce insulin to 0.05 units/kg/hour AND add dextrose 7

Important pitfall: The lag between adding dextrose and reducing insulin rate increases hypoglycemia risk - these adjustments should occur simultaneously 7.

Potassium Management

Hypokalaemia occurs in ~50% of cases and severe hypokalaemia (<2.5 mEq/L) increases mortality 8

  • Never start insulin if K+ <3.3 mEq/L - replete potassium first 1
  • Add potassium to IV fluids as 1/3 potassium phosphate and 2/3 potassium chloride or acetate 1
  • Monitor potassium every 2-4 hours throughout treatment

Bicarbonate

Avoid bicarbonate administration except in rare cases where severe acidosis interferes with myocardial contractility 6. Bicarbonate increases cerebral edema risk in pediatric DKA.

Cerebral Injury Prevention

Infants are at highest risk for cerebral edema, the leading cause of DKA mortality in children 9, 5:

  • Avoid rapid fluid administration
  • Avoid rapid glucose correction (target 50-75 mg/dL/hour decline)
  • Monitor neurological status continuously
  • Warning signs requiring immediate intervention: deteriorating consciousness, severe headache, bradycardia, rising blood pressure

Resolution Criteria

Continue treatment until:

  • Glucose <200 mg/dL
  • Venous pH >7.3
  • Bicarbonate >15 mEq/L
  • Anion gap normalized
  • Blood β-hydroxybutyrate normalized 1, 2

Note: Ketonemia takes longer to clear than hyperglycemia - use β-hydroxybutyrate measurement, not nitroprusside method which only measures acetoacetate and can falsely suggest worsening ketosis during treatment 1.

Transition to Subcutaneous Insulin

Once DKA resolved and infant stable for 4-6 hours:

  • Calculate total daily dose from average insulin infusion rate over preceding 12 hours (e.g., 1.5 units/hour × 24 = 36 units/day)
  • Overlap subcutaneous and IV insulin appropriately based on insulin type used 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.